Article and Video CATEGORIES

Cancer Journey

Search By

Carlea has over 20 years of experience in nonprofit management and health advocacy. In October 2013, she joined The Global Resource for Advancing Cancer Education as its first executive director. She directs its growth in revenue, outreach and programs.

30 Days of Clinical Trials, Victories, and Gratitude

With the Thanksgiving holiday in November, the month has become synonymous with gratitude in the U.S. November is also Lung Cancer Awareness Month; an initiative started in 1995 to increase knowledge of the disease. 

GRACE decided to combine the two ideas. For the next month, we will post videos, images and blog posts where a patient, caregiver, or doctor highlights a currently- or soon-to-be enrolling clinical trial, a victory against lung cancer, or their gratitude in the realm of lung cancer.

November is Lung Cancer Awareness Month. What are you grateful for?
November is Lung Cancer Awareness Month. What are you grateful for?
Photo by Gilles Frydman/Smart Patients

What we want to accomplish is threefold:

- First and foremost, we want more lung cancer patients talking to their doctors about clinical trials. GRACE’s team of faculty will highlight 15 trials that they think are the most exciting. 

- Secondly, we want to celebrate the moments of beauty that arise even during some of the toughest days of our lives. We asked doctors, patients, and caregivers to tell us, “In the world of lung cancer, what are you grateful for?” 

- Finally, we hope to give patients and caregivers a peek at the softer side of their medical teams. The doctors who participated in this initiative did so out of love, admiration and – yes – gratitude for their patients. 

And speaking of gratitude, I’d like to thank the doctors, patients, and caregivers who gave some pretty personal answers for our videos. Thank you to the doctors and researchers who are searching for answers through clinical trials. And thank you to Smart Patients, Celgene, Boehringer-Ingelheim, and Astra Zeneca for their support our gratitude campaign.

 

Next Previous link

Previous PostNext Post

Related Content

Image
Trial data ASCO 2024
Video
In this video series from ASCO 2024, Drs. Aakash Desai and Fauwzi Abu Rous discuss trial dates and clinical data as presented at the 2024 ASCO. To watch the complete playlist, click here.         
Image
Bladder Cancer Video Library 2024
Video
Dr. Petros Grivas discusses intravesical treatment for patients with nonmuscle invasive, or early-stage, bladder cancer, the importance of participating in clinical trials for bladder cancer, combination therapy options for patients with metastatic or incurable bladder cancer, and the importance of family history of cancer and discussing that history with your doctor.
Image
Case Based Panel
Video
The panel discusses treatment options for a patient diagnosed with EGFR Exon 19 Deletion NSCLC and examines data from the Laura Trial, a patient with a smoking history and diagnosis of small cell lung cancer, and how the Adriatic Study factors into decisions, and a patient with NSCLC adenocarcinoma, and a EGFR Exon 21 L858R Alteration, and how data from the Flaura 2 Trial can impact treatment decisions.

Forum Discussions

Hi elysianfields and welcome to Grace.  I'm sorry to hear about your father's progression. 

 

Unfortunately, lepto remains a difficult area to treat.  Recently FDA approved the combo Lazertinib and Amivantamab...

Hello Janine, thank you for your reply.

Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...

Hi elysianfields,

 

That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...

Recent Comments

JOIN THE CONVERSATION
I could not find any info on…
By JanineT GRACE … on
Hi elysianfields,

 

That's…
By JanineT GRACE … on
Hello Janine, thank you for…
By elysianfields on
EGFR
By happybluesun on